Actos and Bladder Cancer

Actos and Bladder Cancer 2016-06-03T11:35:52+00:00

actos_bladdercancerIf you have been taking Actos for more than a year and have been diagnosed with bladder cancer, the drug may be responsible for your cancer. After one year of taking Actos, your risk of bladder cancer may be increased by 40%, according to studies performed by the FDA and European regulators. With millions of people taking the drug, hundreds–mostly men–are expected to develop bladder cancer due to Actos use. If you are facing bladder cancer after taking Actos, you may be able to receive compensation for medical bills, lost wages, and diminished quality of life.

This page contains some background information on the connection between Actos and bladder cancer, but the best way to learn whether you may be able to receive compensation for your injuries is with a free case evaluation from the dedicated personal injury lawyers at Techmeier Law Firm. Please contact us today to talk to one of our experts about your injuries.

What Is Actos?

Actos is a drug to help with treatment of type 2 diabetes, sometimes described as adult onset or noninsulin dependent diabetes. In type 2 diabetes, your body produces enough insulin, but the insulin is not effective in stimulating cells to take glucose in where it can be stored and used for energy. You may experience infections, fatigue, hunger, thirst, increased urination, blurred vision, or erectile dysfunction.

Because type 2 diabetes is a lifelong condition, it requires lifetime medication. Many different types of type 2 diabetes medications are available, and some may be more effective than others at treating your type 2 diabetes. In addition, these drugs have widely varying risk levels, and in order for you and your doctor to make informed decisions about which drug is right for you, manufacturers must carefully study the risks of their drugs and make these risks public.

Actos and Bladder Cancer

Researchers have long suspected the link between Actos and bladder cancer. In 1999, the manufacturer submitted data from a carcinogenic study where male rats developed bladder tumors after being given a dose equivalent to the normal human dose. Female rats did not develop bladder cancer despite being given 11 times the normal human dose. Despite this evidence, information about bladder cancer was not added to the drug’s initial labeling.

Instead, the manufacturer, Takeda, argued that the appearance of cancer in rats did not signal a risk for humans, but, if the drug were approved, they would study that risk in a ten-year study. The story sounds very similar to the actions of Avandia manufacturer GlaxoSmithKline with respect to heart failure.

Now, though, evidence from human treatment with Actos bears out the evidence of the carcinogenic study of 1999. Evidence from several studies shows that Actos may be associated with an up to 40% increase in the risk of bladder cancer among Actos users. French studies even show the same distribution of cancers: men get them, while women generally don’t.

Drugs Should Be Safe before Marketing

Drug manufacturers have a responsibility to ensure the safety of their drugs before they put them on the market. The US Supreme Court has made it clear that drug manufacturers are responsible for ensuring their drugs are properly labeled, not the FDA or other regulatory bodies. However, many manufacturers would rather market their dangerous drugs first and check safety later, using you as their test rat. The motivation is simple: money. Drug makers hope to make their profit before people learn how dangerous a drug is.

If you have been hurt as a result of taking Actos or another prescription drug, your pharmaceutical injury lawsuit can help change the system. By diminishing the profit manufacturers make from this strategy, you can show them that smart business means making a drug safe before it is marketed. Don’t let dangerous drug manufacturers profit off the lives they have destroyed.

Why Choose Techmeier Law Firm of Wisconsin

If you are taking on a powerful opponent like a pharmaceutical company, you need a powerful ally. Techmeier Law Firm is a nationwide law firm with the resources, dedication, and skill necessary to take on any opponent, no matter the size. We have a longstanding tradition of helping individuals like you to stand against seemingly impossible odds and win. When you put your case in the hands of Techmeier Law Firm, you can be assured that it will never lack the legal strength necessary to give it the best odds of success.

Techmeier Law Firm is still a local law firm, under the leadership of local attorney Will Techmeier, who has been helping the people of Wisconsin fight for their rights for over 40 years. Combining the nationwide resources of Techmeier Law Firm with the local leadership and personal commitment of lawyers like Will Techmeier means you will receive personal attention and your case will get the resources that will give you the best chance of success against powerful opponents.

To learn whether you may be able to receive compensation due to this or another type of drug injury, please schedule a free case evaluation with Techmeier Law Firm today.